Resonant Capital Advisors, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1803236 Madison, WI

Position in BMRN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$321,519

New position

Shares Held

5,619

first reported quarter

Ownership

0.003%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#379

of 561 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Resonant Capital Advisors, LLC holds $2,648,282 across 5 Biotechnology names. BMRN ranks #4 (12.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,726	$857,355
2	EXEL	Exelixis, Inc.	14,229	$774,199
3	INCY	Incyte Corp	3,410	$386,557
4	BMRN	Biomarin Pharmaceutical Inc This page	5,619	$321,519
5	REGN	Regeneron Pharmaceuticals, Inc.	495	$308,652

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$321,519	5,619	—	Shares	Sole	2026-07-27
No filing history on record for this holder in this stock.